WO2016135604A1 - Treatment of bone fractures - Google Patents
Treatment of bone fractures Download PDFInfo
- Publication number
- WO2016135604A1 WO2016135604A1 PCT/IB2016/050925 IB2016050925W WO2016135604A1 WO 2016135604 A1 WO2016135604 A1 WO 2016135604A1 IB 2016050925 W IB2016050925 W IB 2016050925W WO 2016135604 A1 WO2016135604 A1 WO 2016135604A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- band
- ultrasonic
- ultrasonic transducers
- controller
- transducers
- Prior art date
Links
- 208000010392 Bone Fractures Diseases 0.000 title description 48
- 238000000034 method Methods 0.000 claims abstract description 42
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 19
- 230000004044 response Effects 0.000 claims description 15
- 210000003414 extremity Anatomy 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 6
- 229920002334 Spandex Polymers 0.000 claims description 5
- 210000002303 tibia Anatomy 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 4
- 239000004759 spandex Substances 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 206010017076 Fracture Diseases 0.000 description 37
- 238000002604 ultrasonography Methods 0.000 description 29
- 230000035876 healing Effects 0.000 description 17
- 210000002414 leg Anatomy 0.000 description 11
- 238000012544 monitoring process Methods 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 208000004367 Tibial Fractures Diseases 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 206010028289 Muscle atrophy Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001699 lower leg Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000020763 muscle atrophy Effects 0.000 description 3
- 201000000585 muscular atrophy Diseases 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010051055 Deep vein thrombosis Diseases 0.000 description 2
- 206010047249 Venous thrombosis Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/395—Details of stimulation, e.g. nerve stimulation to elicit EMG response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/6812—Orthopaedic devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0484—Garment electrodes worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0535—Impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0875—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of bone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0013—Fracture healing
Definitions
- controller 38 is fabricated on a printed circuit board (PCB), e.g., in an Application-Specific Integrated Circuit (ASIC), such as a system-on-chip (SoC).
- PCB printed circuit board
- ASIC Application-Specific Integrated Circuit
- SoC system-on-chip
- controller 38 may be implemented as a combination of separate components, including at least a microcontroller and suitable analog-to-digital and digital-to-analog conversion circuitry for interfacing between the microcontroller and the transducers and electrodes.
- the controller circuitry typically includes a processor (e.g., a firmware-based processor), configured to execute program instructions (provided, for example, in microcode) that cause the processor to carry out the various tasks described herein.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Surgical Instruments (AREA)
Abstract
Apparatus and methods are described, including apparatus that comprises a band (26). One or more ultrasonic transducers (36a, 36b, 36c), and a controller (38), are coupled to the band. The controller is configured to cause at least one of the ultrasonic transducers to transmit an ultrasonic wave toward a fracture (34) of a bone (24) of a subject. Other embodiments are also described.
Description
TREATMENT OF BONE FRACTURES
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application claims the benefit of US Provisional Application 62/1 19,827, filed February 24, 2015, whose disclosure is incorporated herein by reference. FIE LD OF THE IN VENTION
Embodiments of the present invention relate generally to the field of medical devices, and in particular, to apparatus and methods for the treatment of bone fractures.
BACKGROUND
The use of Low-Intensity Pulsed Ultrasound (LIPUS) in treating bone fractures, such as tibial fractures, has been documented. For example, the following journal articles are relevant in this regard:
(i) Heckman, James D., et al, "Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound," The Journal of Bone & Joint Surgery 76.1 (1994): 26-34;
(ii) Leung, Kwok-Sui, et al, "Complex tibial fracture outcomes following treatment with low-intensity pulsed ultrasound," Ultrasound in medicine & biology 30.3 (2004): 389-395;
(iii) Walker, Nicol A., Craig R. Denegar, and Jody Preische, "Low-intensity pulsed ultrasound and pulsed electromagnetic field in the treatment of tibial fractures: a systematic review," Journal of athletic training 42.4 (2007): 530; and
(iv) Mundi, Raman, et al. "Low-intensity pulsed ultrasound: Fracture healing," Indian ournal of orthopaedics 43.2 (2009): 132.
In addition, US Patent Application Publication 2008/0021327, whose disclosure is incorporated herein by reference, discloses ultrasound stimulation devices and related techniques. An ultrasound transducer for generating ultrasound energy is carried by a transducer housing that seals the transducer and may also include a positioning element for positioning the transducer proximate an application area to which generated ultrasound energy is to be applied. The transducer housing may also carry such components as a battery, a wireless receiver, and a controller. The same housing or a separate sensor housing may include an ultrasound sensor that provides feedback to the ultrasound transducer or its controller, illustratively through a wireless transmitter.
Ultrasound may also be used to monitor bone fracture healing. Protopappas, Vasilios C, et al, "Ultrasonic monitoring of bone fracture healing," Ultrasonics, Ferroelectrics, and Frequency Control, IEEE Transactions on 55.6 (2008): 1243-1255, reviews the relevant literature in this regard.
Additionally, Al-Nashash, Hasan, et al, "Quantification of the bone healing process using information of B-Mode ultrasound image," Engineering in Medicine and Biology Society (EMBC), 2012 Annual International Conference of the IEEE, IEEE, 2012, develops a quantitative measure towards assessment and monitoring of the bone healing process. Information theoretic criterion (KLD) was used to quantify the degree of bone healing using the intensity histogram of the callus region obtained from B-Mode ultrasound.
SUMMARY OF THE INVENTION
There is provided, in accordance with some embodiments of the present invention, apparatus that includes a band, one or more ultrasonic transducers coupled to the band, and a controller coupled to the band. The controller is configured to cause at least one of the ultrasonic transducers to transmit an ultrasonic wave toward a fracture of a bone of a subject.
In some embodiments, a thickness of each of the ultrasonic transducers is less than 1 cm.
In some embodiments, a surface area of a front face of each of the ultrasonic transducers is less than 2 cm .
In some embodiments, the band is configured to wrap around a limb of the subject that contains the bone.
In some embodiments, a combined thickness of the band, the transducers, and the controller is less than 1 cm.
In some embodiments, the ultrasonic wave has a frequency of between 800 kHz and 1.5
MHz.
In some embodiments, the ultrasonic wave has a frequency of between 3 and 5 MHz.
In some embodiments, the one or more ultrasonic transducers include:
a first ultrasonic transducer, which is configured to transmit the ultrasonic wave; and a second ultrasonic transducer, configured to:
receive a reflection of the ultrasonic wave, and
in response to the reflection, generate a signal.
In some embodiments, the controller is further configured to:
receive the signal from the second ultrasonic transducer, and
in response to the signal from the second ultrasonic transducer, generate a wireless signal.
In some embodiments, the controller is further configured to, by processing the signal from the second ultrasonic transducer, derive an indication of a status of the fracture, and the wireless signal includes the indication.
In some embodiments, the apparatus further includes at least one processor configured to: receive the wireless signal , and
in response to the wireless signal, generate an output that indicates a status of the fracture.
In some embodiments, the apparatus further includes a mobile device, the processor being a processor of the mobile device.
In some embodiments, the band includes a material selected from the group consisting of: spandex and cotton.
In some embodiments, the apparatus further includes a plurality of electrodes coupled to the band, the controller being further configured to cause the electrodes to pass an electric current between the electrodes.
There is further provided, in accordance with some embodiments of the present invention, a method that includes placing a band on a portion of a body of a subject, one or more ultrasonic transducers being coupled to the band, and subsequently, causing at least one of the ultrasonic transducers to transmit an ultrasonic wave toward a fracture of a bone that is contained within the portion of the body of the subject.
In some embodiments, the bone is a tibia of the subject.
In some embodiments, the method further includes placing a cast over the band.
In some embodiments, placing the cast over the band includes placing the cast over the band such that the ultrasonic transducers are embedded in the cast.
In some embodiments, the at least one of the ultrasonic transducers includes an array of ultrasonic transducers, and the method includes causing the at least one of the ultrasonic transducers to transmit the ultrasonic wave by causing the array of ultrasonic transducers to transmit an ultrasonic beam.
There is further provided, in accordance with some embodiments of the present invention, a method of manufacture. The method includes coupling, to a band, one or more ultrasonic transducers, and a controller, configured to cause at least one of the ultrasonic transducers to transmit an ultrasonic wave toward a fracture of a bone of a subject. The method further includes connecting the ultrasonic transducers to the controller.
The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a schematic illustration of apparatus for treating a bone fracture, in accordance with some embodiments of the present invention.
DETAILED DESCRIPTION OF EMBODIMENTS OVERVIEW
In many cases, to treat a fractured bone, a cast is placed over the limb that contains the bone. The cast stabilizes the bone, thus promoting the healing process. For example, a fractured tibia may be treated by placing a cast over the lower leg of the subj ect.
Although helpful in promoting the healing of the fracture, the application of a cast presents certain challenges. First, the cast may inhibit the use of the LIPUS techniques outlined above in the Background, in that it may not be possible to transmit ultrasound waves through the cast. Moreover, the immobilization of the limb may lead to muscle atrophy, and/or deep vein thrombosis (DVT), in which dangerous blood clots form. (The latter risk is especially relevant to the legs.)
To address the above challenges, embodiments of the present invention provide a thin band that has one or more ultrasonic transducers, such as piezoelectric or capacitive transducers, coupled thereto. The band is placed around the limb of the subject, prior to placement of the cast over the band. Subsequently, to promote healing of the fracture, the ultrasonic transducers are used to apply LIPUS therapy. Typically, in addition, electrodes coupled to the band are used to electrostimulate the muscles of the subject, thus helping to prevent muscle atrophy, and/or increasing blood flow, thus helping to prevent the formation of blood clots.
In some embodiments, the ultrasonic transducers are, alternatively or additionally, used to monitor the healing process, such as by acquiring ultrasound images of the fracture site, or by use of non-imaging ultrasound techniques. Such monitoring allows the physician to treat the
fracture more effectively, thus facilitating a faster and more complete healing process. In addition, such monitoring may allow the physician to properly time the removal of the cast.
A controller, which is also coupled to the band, controls the operation of the ultrasonic transducers and electrodes. In some embodiments, the controller is configured to wirelessly communicate with a mobile device. The mobile device may, for example, provide relevant firmware updates to the controller, and/or communicate instructions to the controller regarding the therapeutic programs and/or parameters to use. Conversely, the controller may communicate, to the mobile device, information received from the ultrasonic transducers and/or electrodes. APPARATUS DESCRIPTION
Reference is made to Fig. 1, which is a schematic illustration of apparatus 20 for treating a bone fracture, in accordance with some embodiments of the present invention. Fig. 1 shows a front view and a back view of a leg 22 of a subject, leg 22 having a fractured tibia 24. As described in detail below, apparatus 20 may be used to treat such a fracture, along with other types of bone fractures in any relevant portion of a body of a subject, including, for example, an arm, a wrist, or an ankle.
Apparatus 20 comprises a band 26, which has one or more ultrasonic transducers coupled thereto. For example, Fig. 1 shows three such ultrasonic transducers 36a, 36b, and 36c. Prior to placing a cast over the leg, band 26 is placed around the leg, such that the ultrasonic transducers are near the fracture 34 in tibia 24. Subsequently, if required, a cast, and/or other stabilizing apparatus (such as a brace), may be placed over the band. Apparatus 20 is typically relatively thin, such that the apparatus does not inhibit the placement of a cast around the fracture. For example, the combined thickness of the band and all of the components coupled thereto (e.g., the controller, the transducers, and the electrodes) may be less than 1 cm. More specifically, the thickness of the band itself may be less than 5 mm, e.g., around 2 mm. Although the transducers protrude from the band (thus bringing the combined thickness of the apparatus closer to 1 cm), the transducers may be embedded in the cast, such that less than 5 mm, e.g., only around 2 mm, separate between the cast and the skin.
In general, the term "band," as used throughout the present application (including the claims), refers to any suitable strip of material to which the relevant components described herein (such as ultrasonic transducers 36a-c) may be coupled. Band 26 may be embodied, for example, as a sleeve, a cuff, a sock, a wrap, a brace, a bracelet, a bandage, a strip, a thimble, a glove, or a patch. Band 26 may be made of any suitable material(s), including, for example,
cotton and/or spandex (also known as elastane), such as a blend of cotton and spandex. (In other words, the band may consist entirely of such materials, or at least most of the band - e.g., at least 50%, 80%, or 90% of the band - may consist of such materials.) The band is typically sized in proportion to the portion of the subject's body over which the band is intended to be placed. For example, a band that is designated for placement around the lower leg may have a length and/or width of between 5 and 30 cm.
In some embodiments, band 26 is wrapped (partially, or fully) around the relevant portion of the subject's body, such as a limb of the subject (e.g., the subject's leg). In some embodiments, the band is then fastened to itself. For example, band 26 may comprise snap fasteners, hook-and-loop fasteners, and/or ties, which allow band 26 to be fastened to itself, thus facilitating a secure fit around the leg. Alternatively or additionally, a secure fit may be achieved by virtue of the band being stretchable, and/or by use of an adhesive material to secure the band to the skin.
In some embodiments, apparatus 20 comprises a single ultrasonic transducer, which performs both the transmitting and receiving functions described below. Typically, however, apparatus 20 comprises a plurality of ultrasonic transducers, with one of the transducers being used as a transmitting transducer, and one or more other transducers being used as receiving transducers. In such embodiments, the band is placed around the leg such that the transmitting transducer is directly over (or at least immediately adjacent to) the fracture, with the receiving transducers being disposed adjacent to the transmitting transducer, near the fracture. Thus, for example, Fig. 1 shows a transmitting transducer 36a directly over fracture 34, with receiving transducers 36b and 36c adjacent to transducer 36a, on opposite sides of the fracture. (It is noted that the transducers are typically structurally identical to each other, and that a transmitting transducer may be used for receiving, and vice versa) Typically, upon placing the band around the leg, the physician aligns the transducers with respect to the fracture, by referring to radiological images (e.g., X-ray images) of the leg. Additionally, the transducers may be aligned based on ultrasound reflections received from the fracture site. Such reflections also provide baseline information that can later be used for monitoring the healing process.
In general, the ultrasonic transducers coupled to the band are miniature in size. For example, the thickness of each of the transducers may be less than 1 cm, and/or the surface area of the front face of each of the transducers (i.e., the face of the transducer that faces the skin of the subject and performs transmitting and/or receiving functions) may be less than 2 cm .
Apparatus 20 further comprises a controller 38, which is also coupled to the band.
Controller 38 comprises circuitry configured to control the ultrasonic transducers, and/or receive data from the transducers, via wired connections between the controller and the transducers. For example, as further described below, the controller causes transmitting transducer 36a to transmit ultrasonic waves toward the bone fracture. Controller 38 typically further comprises a wireless transceiver, such as a Bluetooth Low Energy (BLE) transceiver, and an antenna, which allow the controller to wirelessly communicate with other devices, as further described below. Typically, the circuitry of controller 38 is fabricated on a printed circuit board (PCB), e.g., in an Application-Specific Integrated Circuit (ASIC), such as a system-on-chip (SoC). Alternatively, controller 38 may be implemented as a combination of separate components, including at least a microcontroller and suitable analog-to-digital and digital-to-analog conversion circuitry for interfacing between the microcontroller and the transducers and electrodes. In any case, the controller circuitry typically includes a processor (e.g., a firmware-based processor), configured to execute program instructions (provided, for example, in microcode) that cause the processor to carry out the various tasks described herein.
The controller further comprises a power source, configured to provide power to the controller. Typically, the controller consumes relatively little power, such that the power source need not be recharged for the entire duration of the healing process, assuming that the apparatus is used "normally" as described hereinbelow. For example, the power source may power the controller for at least 60 days, which, for most bone fractures, is sufficient time for completion of the healing process.
Typically, apparatus 20 further comprises a plurality of electrodes, which are used for electrostimulating the subject, and/or acquiring physiological measurements. For example, Fig. 1 shows two stimulating electrodes 30a and 30b, and two sensing electrodes 32a and 32b. Electrodes 30a-b and 32a-b are coupled to the band such that, upon the band being placed over the lower leg as shown, the electrodes are positioned over the calf of the leg. The controller, via wired connections to the electrodes, controls the electrodes, and/or receives data from the electrodes. In some embodiments, an adhesive material is used to adhere the electrodes to the skin.
It is noted that, in some embodiments, at least some of the connections between the controller and the transducers, and/or between the controller and the electrodes, are wireless connections. It is further noted that the scope of the present disclosure includes coupling any suitable number of transducers, and/or any suitable number of electrodes, to the band.
To manufacture apparatus 20, the ultrasonic transducers, electrodes, and controller are
coupled to the band, and the controller is connected to each of the transducers and electrodes. Typically, the transducers and controller are coupled to the band by an adhesive material, and/or by fasteners, such as hook-and-loop fasteners. The electrodes may be similarly coupled to the band. Alternatively, the electrodes may be printed onto, or woven into, the band. TREATMENT AND MONITORING
As described above, the controller causes transmitting transducer 36a to transmit ultrasonic waves toward the facture. For example, the controller may cause the transmitting transducer to periodically provide LIPUS treatment, by transmitting relatively low-frequency ultrasound waves toward the fracture. Thus, for example, ultrasonic pulses having a frequency of between 800 kHz and 1.5 MHz may be applied to the fracture, once a day, for approximately 20-30 minutes, to expedite the healing process. Such pulses may be delivered, for example, at a pulse repetition frequency (PRF) of approximately 1 kHz, with a duty cycle of approximately 20%. (Alternatively, any other suitable PRF and duty cycle may be used.) Typically, in providing such treatment, the emitted power is on the order of 30 mW/cm2.
Alternatively or additionally, the controller may cause the transmitting transducer to, at regular intervals and/or on an ad-hoc basis (e.g., in response to instructions communicated wirelessly to the controller), transmit higher-frequency (e.g., 3-5 MHz, such as approximately 3.5 MHz) ultrasound waves toward the fracture. (Typically, the transmitting transducer is positioned such that the fracture is located at the beginning of the far field of these higher- frequency ultrasound waves.) These ultrasound waves "probe" the fracture site, in that reflections of these waves from bone tissue at the site of the fracture give indication as to the status of the fracture. The reflections are received by receiving transducers 36b and 36c, which generate electric signals in response to the reflections. The controller receives these signals, and, typically, processes the signals such as to derive an indication of the status of the fracture. The controller then generates a wireless signal, which includes the indication of the status of the fracture.
Typically, the wireless signal is received by a processor 42 of a mobile device 40, such as a smartphone or tablet computer belonging to the subject. In response to the wireless signal, processor 42 generates an output (e.g., a visual output displayed on the mobile device) that indicates the status of the fracture. For example, the output may show a particular quantitative metric that describes the current status of the fracture, along with a baseline value for the metric (e.g., a baseline value that was computed upon the initial placement of the apparatus over the fracture), such that the subject may assess any improvement relative to the baseline.
More specifically, the probing may be performed in accordance with either one of the following two methods:
(i) In some embodiments, apparatus 20 comprises an array of transmitting transducers, i.e., transmitting transducer 36a is actually an array of transducers. In such embodiments, the transmitting array may be used (by altematingly enabling and disabling the transducers in the array, and/or by using beamforming techniques) to direct ultrasound beams to various portions of the fracture site, thus allowing for acquisition of an ultrasound image. (The beams typically have a frequency of 3-5 MHz, e.g., approximately 3.5 MHz.) Based on the acquired image, the status of the fracture may be ascertained, using, for example, techniques described in the above- cited reference to Al-Nashash et al, which is incorporated herein by reference.
(ii) In other embodiments, a non-imaging ultrasound technique, such as the axial transmission technique described in the above-cited reference to Protopappas et al, which is incorporated herein by reference, is employed. In brief, the axial transmission technique measures the time required for an ultrasound wave to pass through the fracture site. (This time is known as the transit time of the first-arriving signal (FAS).) A decrease in this time indicates progress in the healing of the fracture. To use the axial transmission technique, ultrasound pulses may be transmitted, for example, at a frequency of approximately 100 kHz. A single transmitting transducer may be used for this purpose.
Typically, as noted above, the controller processes the received signals from the ultrasonic transducers such as to derive the indication of the status of the fracture, in accordance with one of the two methods described above. Alternatively, the wireless signal from the controller may include merely the "raw" information received from the transducers, and another processor - such as processor 42 - may perform the relevant processing.
Typically, the controller also causes electric currents to be passed between stimulating electrodes 30a and 30b. When the band is worn as shown in Fig. 1, such currents may stimulate activity of the muscle fibers in the gastrocnemius, soleus, tibialis anterior, and/or tibialis posterior muscles, thus causing, for example, contractions of these muscles. The stimulated activity helps prevent muscle atrophy, and/or helps prevent the formation of blood clots. Thus, for example, an atrophy-prevention stimulation session may be conducted twice daily, and/or a blood-clot-prevention stimulation session may be conducted every few hours. The duration of each such session may be, for example, on the order of 20 minutes. Some other example electrostimulation parameters include a modulated frequency of 1-10 Hz (i.e., 1-10 pulses per second), a current of 10-25 mA, and a pulse width of approximately 400 microseconds.
Alternatively, any other suitable parameters may be used. (It is noted that the electrostimulation parameters do not necessarily differ between the atrophy-prevention stimulation sessions and the blood-clot-prevention stimulation sessions.) Typically, electrostimulation and LIPUS treatment are not applied at the same time.
Typically, the sensing electrodes are used to acquire plethysmographic measurements and/or electromyographic measurements. The controller receives the relevant signals from the sensing electrodes, and, in response to the signals, computes relevant parameters, and controls the electrostimulation in response thereto.
For example, International Patent Application PCT/IB2016/050543, whose disclosure is incorporated herein by reference, describes a technique for deriving a measure of blood flow from plethysmographic measurements. In brief, the voltage between the sensing electrodes is measured while a (relatively weak, generally non-stimulating) current is passed between the stimulating electrodes. By dividing the voltage by the amplitude of the current, the impedance between the sensing electrodes is derived. Based on this impedance, the rate of flow of blood between the sensing electrodes is estimated, using a technique that is based on the backward- extrapolation method of Nyboer et al., "Electrical Impedance Plethysmography: A Physical and Physiologic Approach to Peripheral Vascular Study," Circulation 2.6 (1950): 811-821, which is incorporated herein by reference. In response to the estimate of blood flow, the controller may increase or decrease the electrostimulation of the subject. Likewise, based on the level of muscular activity indicated by the electromyographic signals, the controller may increase or decrease the electrostimulation of the subject.
In some embodiments, the same electrodes are used for acquiring both plethysmographic and electromyographic measurements. In other embodiments, separate electrodes are used for each function.
Typically, mobile device 40 communicates with a remote server 44. Remote server 44, via the mobile device, provides firmware updates to the controller, and/or communicates instructions to the controller that cause the controller to start or abort ultrasound transmission or electrostimulation, select particular LIPUS or electrostimulation programs or parameters, and/or perform any relevant tasks. Conversely, the controller, via the mobile device, communicates relevant information concerning the status of the subject, such as the current status of the fracture. The remote server (and/or any other device in communication with the remote server) may present such information for viewing by the subject's physician. In this manner, the physician may monitor the healing process, such as to more effectively (i) decide whether further
probing, surgical intervention, or physical therapy is needed, (ii) time the removal of the cast, and/or (iii) make any other relevant decisions. Alternatively or additionally, the remote server may use the information (in combination with similar information from other subjects) to further optimize the LIPUS and/or electrostimulation parameters.
The controller is typically configured (in hardware, firmware, and/or software) to perform any relevant digital signal processing (DSP) functions involved in the probing techniques described above. Alternatively or additionally, such DSP functions may be performed by processor 42, and/or by any other processor, such as a processor of remote server 44. Similarly, any other relevant computational task described herein - such as calculating suitable LIPUS or electrostimulation parameters, or processing feedback from the electrodes - may be assigned to any one of the controller, processor 42, and remote server 44. In some embodiments, some computational tasks may be distributed over two or more of the controller, processor 42, and remote server 44, and/or any other processor(s).
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims
1. Apparatus, comprising:
a band;
one or more ultrasonic transducers coupled to the band; and
a controller coupled to the band, the controller being configured to cause at least one of the ultrasonic transducers to transmit an ultrasonic wave toward a fracture of a bone of a subject.
2. The apparatus according to claim 1, wherein a thickness of each of the ultrasonic transducers is less than 1 cm.
3. The apparatus according to claim 1, wherein a surface area of a front face of each of the
2
ultrasonic transducers is less than 2 cm .
4. The apparatus according to claim 1, wherein the band is configured to wrap around a limb of the subject that contains the bone.
5. The apparatus according to claim 1, wherein a combined thickness of the band, the transducers, and the controller is less than 1 cm.
6. The apparatus according to claim 1, wherein the ultrasonic wave has a frequency of between 800 kHz and 1.5 MHz.
7. The apparatus according to claim 1, wherein the ultrasonic wave has a frequency of between 3 and 5 MHz.
8. The apparatus according to any one of claims 1-7, wherein the one or more ultrasonic transducers comprise:
a first ultrasonic transducer, which is configured to transmit the ultrasonic wave; and a second ultrasonic transducer, configured to:
receive a reflection of the ultrasonic wave, and
in response to the reflection, generate a signal.
9. The apparatus according to claim 8, wherein the controller is further configured to:
receive the signal from the second ultrasonic transducer, and
in response to the signal from the second ultrasonic transducer, generate a wireless signal.
10. The apparatus according to claim 9, wherein the controller is further configured to, by processing the signal from the second ultrasonic transducer, derive an indication of a status of the fracture, and wherein the wireless signal includes the indication.
11. The apparatus according to claim 9, further comprising at least one processor configured to:
receive the wireless signal, and
in response to the wireless signal, generate an output that indicates a status of the fracture.
12. The apparatus according to claim 11, further comprising a mobile device, the processor being a processor of the mobile device.
13. The apparatus according to any one of claims 1-7, wherein the band comprises a material selected from the group consisting of: spandex and cotton.
14. The apparatus according to any one of claims 1-7, wherein the one or more ultrasonic transducers comprise at least one array of ultrasonic transducers.
15. The apparatus according to any one of claims 1-7, further comprising a plurality of electrodes coupled to the band, the controller being further configured to cause the electrodes to pass an electric current between the electrodes.
16. A method, comprising:
placing a band on a portion of a body of a subject, one or more ultrasonic transducers being coupled to the band; and
subsequently, causing at least one of the ultrasonic transducers to transmit an ultrasonic wave toward a fracture of a bone that is contained within the portion of the body of the subject.
17. The method according to claim 16, wherein the portion of the body of the subject is a limb of the subject, and wherein placing the band on the limb of the subject comprises wrapping the band around the limb of the subject.
18. The method according to claim 16, wherein the bone is a tibia of the subject.
19. The method according to claim 16, wherein the ultrasonic wave has a frequency of between 800 kHz and 1.5 MHz.
20. The method according to claim 16, wherein the ultrasonic wave has a frequency of between 3 and 5 MHz.
21. The method according to any one of claims 16-20, wherein the at least one of the ultrasonic transducers is a first one of the ultrasonic transducers, and wherein the method further comprises, using a second one of the ultrasonic transducers:
receiving a reflection of the ultrasonic wave; and
in response to the reflection, generating a signal.
22. The method according to claim 21, further comprising:
receiving the signal from the second one of the ultrasonic transducers, and
in response to the signal from the second one of the ultrasonic transducers, generating a wireless signal.
23. The method according to claim 22, further comprising, by processing the signal from the second one of the ultrasonic transducers, deriving an indication of a status of the fracture, wherein the wireless signal includes the indication.
24. The method according to claim 22, further comprising:
receiving the wireless signal, and
in response to the wireless signal, generating an output that indicates a status of the fracture.
25. The method according to any one of claims 16-20, further comprising placing a cast over the band.
26. The method according to claim 25, wherein placing the cast over the band comprises placing the cast over the band such that the ultrasonic transducers are embedded in the cast.
27. The method according to any one of claims 16-20, wherein the at least one of the ultrasonic transducers includes an array of ultrasonic transducers, and wherein the method comprises causing the at least one of the ultrasonic transducers to transmit the ultrasonic wave by causing the array of ultrasonic transducers to transmit an ultrasonic beam.
28. The method according to any one of claims 16-20, wherein a plurality of electrodes are coupled to the band, and wherein the method further comprises, while the band is on the portion of the body of the subject, causing the electrodes to pass an electric current between the electrodes.
29. A method of manufacture, comprising:
coupling, to a band:
one or more ultrasonic transducers, and
a controller, configured to cause at least one of the ultrasonic transducers to transmit an ultrasonic wave toward a fracture of a bone of a subject; and
connecting the ultrasonic transducers to the controller.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562119827P | 2015-02-24 | 2015-02-24 | |
US62/119,827 | 2015-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016135604A1 true WO2016135604A1 (en) | 2016-09-01 |
Family
ID=56787977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2016/050925 WO2016135604A1 (en) | 2015-02-24 | 2016-02-22 | Treatment of bone fractures |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016135604A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10213602B2 (en) | 2015-01-13 | 2019-02-26 | Theranica Bio-Electronics Ltd. | Treatment of headaches by electrical stimulation |
US11167135B2 (en) | 2017-05-21 | 2021-11-09 | Theranica Bio-Electronics Ltd. | Apparatus for providing pain relief therapy |
US11357980B2 (en) | 2016-09-29 | 2022-06-14 | Theranica Bio-Electronics Ltd. | Apparatus for applying an electrical signal to a subject |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996036278A1 (en) * | 1995-05-17 | 1996-11-21 | John G Stark | An orthopedic device supporting two or more treatment systems and associated methods |
EP0800788A1 (en) * | 1996-04-10 | 1997-10-15 | Lec Tec Corporation | Solid ultrasonic biomedical couplant sheet |
US6022349A (en) * | 1997-02-12 | 2000-02-08 | Exogen, Inc. | Method and system for therapeutically treating bone fractures and osteoporosis |
US6432070B1 (en) * | 1999-05-11 | 2002-08-13 | Exogen, Inc. | Method and apparatus for ultrasonic treatment of reflex sympathetic dystrophy |
US6585647B1 (en) * | 1998-07-21 | 2003-07-01 | Alan A. Winder | Method and means for synthetic structural imaging and volume estimation of biological tissue organs |
US20070219470A1 (en) * | 2006-03-08 | 2007-09-20 | Talish Roger J | System and method for providing therapeutic treatment using a combination of ultrasound, electro-stimulation and vibrational stimulation |
US20070238998A1 (en) * | 2006-04-11 | 2007-10-11 | Sdgi Holdings, Inc. | Volumetric measurement and visual feedback of tissues |
US7410469B1 (en) * | 1999-05-21 | 2008-08-12 | Exogen, Inc. | Apparatus and method for ultrasonically and electromagnetically treating tissue |
US20120065479A1 (en) * | 2010-04-26 | 2012-03-15 | Lahiji Rosa R | Ultrasound patch |
US20120232398A1 (en) * | 2010-11-05 | 2012-09-13 | Masoud Roham | Wireless fetal monitoring system |
-
2016
- 2016-02-22 WO PCT/IB2016/050925 patent/WO2016135604A1/en active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996036278A1 (en) * | 1995-05-17 | 1996-11-21 | John G Stark | An orthopedic device supporting two or more treatment systems and associated methods |
EP0800788A1 (en) * | 1996-04-10 | 1997-10-15 | Lec Tec Corporation | Solid ultrasonic biomedical couplant sheet |
US6022349A (en) * | 1997-02-12 | 2000-02-08 | Exogen, Inc. | Method and system for therapeutically treating bone fractures and osteoporosis |
US6585647B1 (en) * | 1998-07-21 | 2003-07-01 | Alan A. Winder | Method and means for synthetic structural imaging and volume estimation of biological tissue organs |
US6432070B1 (en) * | 1999-05-11 | 2002-08-13 | Exogen, Inc. | Method and apparatus for ultrasonic treatment of reflex sympathetic dystrophy |
US7410469B1 (en) * | 1999-05-21 | 2008-08-12 | Exogen, Inc. | Apparatus and method for ultrasonically and electromagnetically treating tissue |
US20070219470A1 (en) * | 2006-03-08 | 2007-09-20 | Talish Roger J | System and method for providing therapeutic treatment using a combination of ultrasound, electro-stimulation and vibrational stimulation |
US20070238998A1 (en) * | 2006-04-11 | 2007-10-11 | Sdgi Holdings, Inc. | Volumetric measurement and visual feedback of tissues |
US20120065479A1 (en) * | 2010-04-26 | 2012-03-15 | Lahiji Rosa R | Ultrasound patch |
US20120232398A1 (en) * | 2010-11-05 | 2012-09-13 | Masoud Roham | Wireless fetal monitoring system |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10213602B2 (en) | 2015-01-13 | 2019-02-26 | Theranica Bio-Electronics Ltd. | Treatment of headaches by electrical stimulation |
US10994135B2 (en) | 2015-01-13 | 2021-05-04 | Theranica Bio-Electronics Ltd. | Treatment of headaches by electrical stimulation |
US11357980B2 (en) | 2016-09-29 | 2022-06-14 | Theranica Bio-Electronics Ltd. | Apparatus for applying an electrical signal to a subject |
US11167135B2 (en) | 2017-05-21 | 2021-11-09 | Theranica Bio-Electronics Ltd. | Apparatus for providing pain relief therapy |
US11904163B2 (en) | 2017-05-21 | 2024-02-20 | Theranica Bio-Electronics Ltd. | Apparatus for providing pain relief therapy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12109441B2 (en) | Extracorporeal therapeutic ultrasound for promoting vasodilation | |
CN110997067B (en) | Internal organ, injury and pain treatment | |
CN103384548B (en) | Skin ulcer treatment | |
KR20030040355A (en) | Device for treating tissues with an electromagnetic field | |
US20170216617A1 (en) | Portable, Pre-calibrated and Wearable Laser Device for Treating Pain and Inflammation | |
WO2013040432A1 (en) | Systems and methods for preventing, managing and/or treating peripheral neuropathy, peripheral vascular disease, erectile dysfunction, urinary incontinence, cellulite and other conditions | |
US10493272B1 (en) | Inferential electrical stimulation device with targeting capabilities | |
RU2647184C2 (en) | Microcirculation enhancement device | |
US20230293887A1 (en) | Systems and methods to reduce sensor interference associated with electrical therapies | |
WO2016135604A1 (en) | Treatment of bone fractures | |
WO2019204639A1 (en) | Extracorporeal therapeutic ultrasound for promoting angiogenesis | |
Broderick et al. | Comparative lower limb hemodynamics using neuromuscular electrical stimulation (NMES) versus intermittent pneumatic compression (IPC) | |
Ammar | Extracorporeal Shock Wave Versus Interferential Current in Tennis Elbow | |
RU2496531C2 (en) | Method for prevention of forearm rotational contracture in colles fractures | |
BERANKOVA et al. | Evaluation of non-invasive body sculpting method based on novel efficient application of high-frequency energy administered to human adipose tissue | |
IT201600073116A1 (en) | A USEFUL AESTHETIC DEVICE TO INCREASE THE REJUVENATION OF A MUCOSA FABRIC |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16754823 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16754823 Country of ref document: EP Kind code of ref document: A1 |